The article offers an update concerning the cochrane pain, palliative and supportive care group (PaPaS). It discusses the number of useful reviews which the group has completed in the last 18 months. The group's latest reviews include a review of studies assessing the efficacy of drugs for the management of cancer-related fatigue (CRF).